9.39
price up icon2.29%   0.21
after-market After Hours: 9.29 -0.10 -1.06%
loading

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Forecast

The Bridgebio Oncology Therapeutics Inc (BBOT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.00, representing a -100.00% decrease from the current price of $9.39. The highest analyst price target is $0.00, and the lowest is $0.00.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BBOT Price Target
Average 0.00 (-100.00% Downside)
loading

Is Bridgebio Oncology Therapeutics Inc (BBOT) A Buy Now?

Oscillators
Name Value Action
RSI(14) 52.53 Neutral
STOCH(9,6) 61.51 Neutral
STOCHRSI(14) 100.00 Sell
MACD(12,26) -0.2234 Buy
ADX(14) 18.63 Neutral
William %R -8.7108 Sell
CCI(14) 149.69 Buy
Buy: 2 Sell: 2 Neutral: 3
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
8.8665
Buy
8.9589
Buy
MA20
8.8898
Buy
9.0569
Buy
MA50
9.7712
Sell
9.7288
Sell
MA100
11.00
Sell
10.35
Sell
MA200
9.3116
Buy
0.00
Buy
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, BBOT could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 6 signaling Sell signals and 3 Neutral signals. This might be a good time to open fresh positions on BBOT, as trading bullish markets is always a lot easier
  1. RSI (Relative Strength Index): The RSI(14) value of 52.53 indicates that BBOT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 61.51 indicates that BBOT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that BBOT is oversold. This suggests that BBOT price is at or near the highest level relative to its recent price history.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 18.63 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 149.69 indicates that BBOT is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.

Bridgebio Oncology Therapeutics Inc Stock (BBOT) Year by Year Forecast

$54.26
price up icon 2.69%
$48.70
price down icon 0.25%
$99.47
price up icon 1.08%
$152.54
price up icon 3.76%
$146.74
price down icon 4.34%
ONC ONC
$319.94
price up icon 3.21%
Cap:     |  Volume (24h):